title: Nalfurafine, the kappa opioid agonist, inhibits icilin-induced wet-dog shakes in rats and antagonizes glutamate release in the dorsal striatum.
abstract: Icilin, a cooling compound, produces vigorous wet-dog shakes in rats. We have reported previously that icilin-induced wet-dog shakes are blocked by the kappa opioid receptor agonists, nalfurafine and U50,488H, and that icilin evokes a dose- and time-dependent increase in glutamate within the dorsal striatum. Since activation of kappa opioid receptors inhibits glutamate release intrastriatally, we targeted glutamate release within the dorsal striatum using nalfurafine and examined the role of the dorsal striatum in icilin-induced wet-dog shakes, more specifically, the effect that icilin-evoked intrastriatal glutamate release has on the overt stimulant behavior. We report that nalfurafine (0.04mg/kg) inhibits icilin (0.50mg/kg)-induced wet-dog shakes and that this inhibition is reversed by intrastriatal perfusion of the kappa opioid receptor antagonist, norbinaltorphimine (100nM). Furthermore,we antagonized icilin-evoked glutamate release with nalfurafine (0.04mg/kg), and reversed inhibition of glutamate release with intrastriatal norbinaltorphimine (100nM). These findings support a central component in the behavioral response to icilin and suggest that activation of kappa opioid receptors antagonizes icilin-induced wet-dog shakes in rats by inhibiting glutamate release within the dorsal striatum.
authors.affiliation: Department of Pharmacology, Temple University Health Sciences Center, PA, Philadelphia, USA.
authors.forename: Jennifer L
authors.initials: JL
authors.lastname: Werkheiser
authors.forename: Scott M
authors.initials: SM
authors.lastname: Rawls
authors.forename: Alan
authors.initials: A
authors.lastname: Cowan
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D019540:Area Under Curve; D001522:Behavior, Animal / Q000187:drug effects; D003342:Corpus Striatum / Q000187:drug effects*; D004347:Drug Interactions; D004563:Electrochemistry / Q000379:methods; D018698:Glutamic Acid / Q000378:metabolism*; D008297:Male; D009019:Morphinans / Q000494:pharmacology*; D011744:Pyrimidinones / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D017473:Receptors, Opioid, kappa / Q000819:agonists*; D012768:Shivering / Q000187:drug effects*; D013141:Spiro Compounds / Q000494:pharmacology*
chemical_list: D009019:Morphinans; D011744:Pyrimidinones; D017473:Receptors, Opioid, kappa; D013141:Spiro Compounds; C111212:TRK 820; D018698:Glutamic Acid; C490483:icilin